GLP-1 Agonists
What Is Retatrutide? A Complete Scientific Overview
Retatrutide is a novel triple GIP/GLP-1/glucagon receptor agonist. Learn about its mechanism of action, clinical trial results, and weight loss potential.
6 min read
Articles tagged "retatrutide"
GLP-1 Agonists
Retatrutide (TRIPLE-G): The Complete Guide to the Triple Agonist
Retatrutide acts on 3 metabolic receptors. -28.7% weight in a trial on 5,800 people. Complete guide to the GLP-1/GIP/Glucagon triple agonist 2026.
16 min read
GLP-1 Agonists
Retatrutide: Phase 2 and Phase 3 Clinical Trial Results
Detailed analysis of retatrutide clinical data: from the Phase 2 NEJM study to Eli Lilly's Phase 3 TRIUMPH program.
7 min read
Peptide Comparisons
Semaglutide vs Tirzepatide vs Retatrutide: A Complete Comparison
Scientific comparison of the three leading GLP-1 peptides: semaglutide, tirzepatide, and retatrutide. Mechanism, efficacy, side effects, and development status.
11 min read
Peptide Comparisons
Best Weight Loss Peptides in 2026
Ranking of the most promising peptides for weight loss research in 2026: retatrutide, tirzepatide, semaglutide, survodutide, and CagriSema.
10 min read